Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2024
Frederick Varn, PhD
Dissecting glioblastoma growth dynamics in the aging brain
Read More
2024
Nan Zhang, PhD
Investigating the role of IL1β in ovarian cancer chemoresistance
Read More
2024
John Prensner, MD, PhD
Upstream open reading frames as unique cancer targets in childhood medulloblastoma
Read More
2024
Yana Pikman, MD
Targeting protein methylation for novel T-cell acute lymphoblastic leukemia therapy
Read More
2024
Courtney Jones, PhD
Targeting eIF5A hypusination in pediatric acute myeloid leukemia
Read More
2024
Quanyin Hu, PhD
In situ engineering next-generation CAR-Macrophages for post-surgical pediatric glioblastoma recurrence treatment
Read More
2024
Elvin Wagenblast, PhD
Modeling and Targeting High-Risk Pediatric Acute Lymphoblastic Leukemia
Read More
2024
Robert Wechsler‐Reya, PhD
Precision Medicine and Precision Delivery for Diffuse Midline Glioma
Read More
2024
Guilherme Nader, PhD
Probing the role of nuclear mechanical confinement in the crosstalk between cancer...
Read More
2024
Christina Termini, PhD
Targeting the leukemia heparan sulfome to overcome chemotherapy resistance
Read More
2024
Megan Ruhland, PhD
Tissue complexity impacts anti-tumor dendritic cell function in melanoma
Read More
2024
Daniel Matson, MD, PhD
GATA2 Enables a Personalized Medicine Approach to Endometrial Serous Carcinoma
Read More
2024
Alex Kentsis, MD, PhD
Epigenetic liabilities for synthetic lethal targeting of refractory childhood sarcomas
Read More
2024
Michael Andreeff, MD, PhD
Co-targeting menin, RAS, and BCL-2 in KMT2A-rearranged pediatric acute leukemias
Read More
2024
M. Kohler, MD, PhD
Signaling Enhanced CAR T Cells for the Treatment of Pediatric Osteosarcoma
Read More
2024
Gabriel Griffin, MD
Harnessing Endogenous Retroviruses to Overcome Immunotherapy Resistance in Microsatellite-Stable Colorectal Cancer
Read More